Foster & Motley Inc. Invests $7.17 Million in MetLife, Inc. $MET

Foster & Motley Inc. acquired a new stake in MetLife, Inc. (NYSE:MET) during the 2nd quarter, Holdings Channel reports. The fund acquired 84,696 shares of the financial services provider’s stock, valued at approximately $7,166,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in MET. Mowery & Schoenfeld Wealth Management LLC bought a new stake in shares of MetLife in the second quarter valued at about $26,000. Activest Wealth Management raised its position in MetLife by 205.8% in the 4th quarter. Activest Wealth Management now owns 315 shares of the financial services provider’s stock valued at $25,000 after buying an additional 212 shares during the last quarter. Garton & Associates Financial Advisors LLC bought a new stake in MetLife in the 4th quarter valued at approximately $30,000. Gunpowder Capital Management LLC dba Oliver Wealth Management bought a new stake in MetLife in the 4th quarter valued at approximately $31,000. Finally, Prosperity Bancshares Inc acquired a new position in MetLife during the 4th quarter worth approximately $31,000. 94.99% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: DOWLING & PARTN raised its fiscal 2027 earnings estimate for MetLife to $10.85 per share from $10.75. The revision suggests improving analyst expectations for the insurer’s future profitability and is favorable for MET, although the new estimate remains above the broader current-year consensus of $9.70. MetLife FY2027 earnings estimate
• Neutral Sentiment: MetLife declared third-quarter 2026 dividends on several series of preferred stock, including Series A, Series D, Series E and Series F. The payments reinforce the company’s ongoing capital-return commitments, but they primarily affect preferred shareholders and are unlikely to materially change the valuation of MET common shares. MetLife preferred stock dividends
• Neutral Sentiment: MetLife published its 2025 sustainability report, highlighting research and insights related to its environmental, social and governance initiatives. The report may support the company’s long-term reputation with stakeholders, but it is not expected to have an immediate earnings impact. MetLife 2025 sustainability report
• Neutral Sentiment: Several headlines concern MetLife Stadium, including a new stadium CEO, rapid transitions between Jets and Giants games, and upcoming concerts. These stories relate to the sports and entertainment venue—not MetLife, Inc.’s insurance and financial-services operations—and should not materially affect MET stock. MetLife Stadium names new CEO

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on MET shares. UBS Group lifted their price objective on shares of MetLife from $102.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 8th. Atlantic Securities set a $103.00 target price on shares of MetLife in a research report on Wednesday, July 15th. Barclays lifted their price target on shares of MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Weiss Ratings upgraded shares of MetLife from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, June 15th. Finally, Morgan Stanley raised their price objective on MetLife from $93.00 to $103.00 and gave the company an “overweight” rating in a report on Monday, July 6th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $101.07.

MetLife Price Performance

Shares of MET opened at $96.83 on Wednesday. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.52. The company’s fifty day simple moving average is $92.00 and its 200 day simple moving average is $81.86. MetLife, Inc. has a 1-year low of $67.33 and a 1-year high of $100.93. The company has a market cap of $62.31 billion, a price-to-earnings ratio of 18.55, a PEG ratio of 0.75 and a beta of 0.78.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $2.43 EPS for the quarter, beating analysts’ consensus estimates of $2.30 by $0.13. The firm had revenue of $13.52 billion during the quarter, compared to analysts’ expectations of $19.67 billion. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The company’s revenue for the quarter was up 10.5% compared to the same quarter last year. During the same quarter last year, the company posted $2.02 earnings per share. On average, research analysts forecast that MetLife, Inc. will post 9.7 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Stockholders of record on Tuesday, August 4th will be paid a dividend of $0.5925 per share. This represents a $2.37 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Tuesday, August 4th. MetLife’s payout ratio is currently 45.40%.

MetLife announced that its board has initiated a stock buyback plan on Wednesday, August 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to purchase up to 4.8% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board of directors believes its stock is undervalued.

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.